Research Article

The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer

Table 1

Clinical characteristics of the liver cancer patients.

CharacteristicsNumbers of cases (%)

Age
 <55117 (31.45)
 ≥55255 (68.55)
Gender
 Female121 (32.44)
 Male252 (67.56)
Histological type
 Fibrolamellar carcinoma3 (0.8)
 Hepatocellular carcinoma363 (97.32)
 Hepatocholangiocarcinoma (mixed)7 (1.88)
Histologic grade
 NA5 (1.34)
 G155 (14.75)
 G2178 (47.72)
 G3123 (32.98)
 G412 (3.22)
Stage
 NA24 (6.43)
 I172 (46.11)
 II87 (23.32)
 III85 (22.79)
 IV5 (1.34)
T classification
 NA2 (0.54)
 T1182 (48.79)
 T295 (25.47)
 T380 (21.45)
 T413 (3.49)
 TX1 (0.27)
N classification
 NA1 (0.27)
 N0253 (67.83)
 N14 (1.07)
 NX115 (30.83)
M classification
 M0267 (71.58)
 M14 (1.07)
 MX102 (27.35)
Radiation therapy
 NA25 (6.7)
 No340 (91.15)
 Yes8 (2.14)
Residual tumor
 NA7 (1.88)
 R0326 (87.4)
 R117 (4.56)
 R21 (0.27)
 RX22 (5.9)
Vital status
 Deceased130 (34.85)
 Living243 (65.15)
Sample type
 Primary tumor371 (99.46)
 Recurrent tumor2 (0.54)
Os_s
 0237 (64.58)
 1130 (35.42)
Rf_s
 0179 (55.94)
 1141 (44.06)
INPP5K
 High225 (60.32)
 Low148 (39.68)
Type
1373 (100)